Pharmalittle: Obesity pill cuts 16% body weight in 44
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Structure Therapeutics unveiled a 44‑week trial where its daily pill achieved ~16% weight loss versus placebo
- Obesity patients could soon have a potent, prescription‑only tool alongside lifestyle changes
- Medical community sees the data as a potential bridge between modest diet‑based results and dramatic surgical outcomes
Why it matters: A 16% weight loss could reshape obesity treatment and curb related health crises.
Ask SkimNews
